Published in Hospital and Nursing Home Week, May 31st, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Dey, L.P.
Report 1: Dey, L.P., a U.S. Affiliate of Merck KGaA of Darmstadt, Germany, announced that Cyanokit(R) 5g (hydroxocobalamin for injection) ANTIDOTE is now commercially available in the United States. Cyanokit was approved by the United States Food and Drug Administration in December 2006 for the treatment of known or suspected cyanide poisoning.
"The availability of Cyanokit marks an important step forward for emergency medicine," said Christy Taylor, Executive Vice...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital and Nursing Home Week